According to the research report titled ‘Platelet Aggregation Devices Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By End Use; By Regions; Segment Forecast, 2020 -2027’, available with Market Study Report, global platelet aggregation devices market is expected to reach a valuation of USD 1,556.8 million by the year 2027.
 

Increased pervasiveness of infectious diseases, especially coronavirus have impelled the demand for advanced serological tests, which in turn is one of the major factors driving the growth of global platelet aggregation devices market. Technological advancements in platelet aggregation device and rising prevalence of chronic conditions are also augmenting the industry remuneration.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963826/
 

In fact, technological breakthroughs have resulted in the development of specialized tests which include lumi-aggregometry and flow cytometry and impedance WBA (whole blood aggregometry), thereby favoring worldwide platelet aggregation devices industry outlook.
 

For those uninitiated, platelet aggregation is the process in which platelet cells collect to prevent bleeding through vasoconstriction for clot formation. The process is usually mediated through a PAF (platelet aggregating factor).
 

Platelet function disorders can be acquired or inherited. The acquired disorders are primarily caused by chronic conditions such as AML (acute myeloid leukemia), CML (chronic myeloid leukemia), MDS (myelodysplastic syndrome), and uremia (kidney failure). Meanwhile, inherited platelet dysfunction consists of storage pool disease (SPD), Bernard-Soulier syndrome, Glanzmann’s thrombasthenia, and Von Willebrand disease.
 

Easy availability of reagents such as ristocetin, epinephrine, vasopressin, ADP, thrombin, and collagen in order to conduct platelet function tests is further aiding global platelet aggregation devices market expansion. Moreover, rising adoption of antiplatelet therapy has revolutionized platelet function testing, which in turn is facilitating the overall business scenario.
 

Based on product landscape, the market is segmented into consumables & accessories, reagents, and systems. In terms of application spectrum, the industry is bifurcated into clinical applications, and research applications. The end-user scope of worldwide platelet aggregation devices industry is classified into blood banks, research academic institutes, diagnostic laboratories, standalone hospitals, and others.
 

Global platelet aggregation devices industry, from the regional point of view, is classified into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
 

Sienco Inc., Aggredyne Inc., Sentinel CH. S.p.A, Helena Laboratories Corp., Accriva Diagnostics Holdings Inc., Siemens Healthineers AG, Sysmex Corp., Haemonetics Corporation, Drucker Diagnostics Inc., and F. Hoffmann La-Roche AG are the major contenders in global platelet aggregation devices market.